Literature DB >> 2753699

Computed tomographic evaluation of regional lymph node involvement in cancer of the oral cavity and oropharynx.

L G Close1, M Merkel, M F Vuitch, J Reisch, S D Schaefer.   

Abstract

To evaluate the efficacy of computed tomography (CT) in the identification of metastatic cervical node involvement from cancer of the oral cavity and oropharynx, 61 consecutive, previously untreated patients with T2 or greater squamous cell carcinoma of these sites were studies prospectively by CT, followed within 1 month by surgery to the primary and neck as initial treatment. The CT scan of each patient was evaluated according to the location, size, and appearance of visible nodes, and each feature was correlated with the histopathologic findings of all 83 neck specimens. A significant relationship was found between CT findings (node size, node appearance, and multiplicity of nodes) and the pathologic status of the neck using Chi-square contingency table analysis (overall chi 2 = 30.928, p less than 0.001). This data supports the role of CT in the evaluation of patients with cancer of these sites.

Entities:  

Mesh:

Year:  1989        PMID: 2753699     DOI: 10.1002/hed.2880110405

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  14 in total

1.  Contribution of doppler sonography blood flow information to the diagnosis of metastatic cervical nodes in patients with head and neck cancer: assessment in relation to anatomic levels of the neck.

Authors:  K Yonetsu; M Sumi; M Izumi; M Ohki; S Eida; T Nakamura
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

2.  Accuracy of MRI for the diagnosis of metastatic cervical lymphadenopathy in patients with thyroid cancer.

Authors:  Qinghua Chen; Prashant Raghavan; Sugoto Mukherjee; Mark J Jameson; James Patrie; Wenjun Xin; Junfang Xian; Zhenchang Wang; Paul A Levine; Max Wintermark
Journal:  Radiol Med       Date:  2015-03-01       Impact factor: 3.469

3.  Value of the supraomohyoid neck dissection with frozen section analysis as a staging procedure in the clinically negative neck in squamous cell carcinoma of the oral cavity.

Authors:  F J van den Hoogen; J J Manni
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

4.  Reproduction of occult metastasis of head and neck cancer in nude mice.

Authors:  S Kawashiri; S Kumagai; K Kojima; H Harada; K Nakagawa; E Yamamoto
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

5.  Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study.

Authors:  M W van den Brekel; J A Castelijns; H V Stel; R P Golding; C J Meyer; G B Snow
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

Review 6.  Diagnosis and treatment of the N0 neck in carcinomas of the upper aerodigestive tract: current status of diagnostic procedures.

Authors:  M Lenz; B Kersting-Sommerhoff; M Gross
Journal:  Eur Arch Otorhinolaryngol       Date:  1993       Impact factor: 2.503

7.  Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study.

Authors:  Patricia A Hudgins; Yoshimi Anzai; Marie R Morris; Maria A Lucas
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

8.  Prevalence and localization of nodal metastases in squamous cell carcinoma of the oral cavity: role and extension of neck dissection.

Authors:  Luca Oscar Redaelli De Zinis; Andrea Bolzoni; Cesare Piazza; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-09-27       Impact factor: 2.503

Review 9.  Management of oral cancer.

Authors:  A E Brown; J D Langdon
Journal:  Ann R Coll Surg Engl       Date:  1995-11       Impact factor: 1.891

Review 10.  What the clinician wants to know: surgical perspective and ultrasound for lymph node imaging of the neck.

Authors:  Michiel W M van den Brekel; Jonas A Castelijns
Journal:  Cancer Imaging       Date:  2005-11-23       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.